These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 29524850)

  • 41. Inhibition of insulin amyloid fibrillation by Morin hydrate.
    Patel P; Parmar K; Das M
    Int J Biol Macromol; 2018 Mar; 108():225-239. PubMed ID: 29197568
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of Ionic Strength on Thioflavin-T Affinity to Amyloid Fibrils and Its Fluorescence Intensity.
    Mikalauskaite K; Ziaunys M; Sneideris T; Smirnovas V
    Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33255444
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Chiral bifurcation in aggregating insulin: an induced circular dichroism study.
    Loksztejn A; Dzwolak W
    J Mol Biol; 2008 May; 379(1):9-16. PubMed ID: 18439622
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Biocompatible Fluorescent Probe for Selective Detection of Amyloid Fibrils.
    Das A; Dutta T; Gadhe L; Koner AL; Saraogi I
    Anal Chem; 2020 Aug; 92(15):10336-10341. PubMed ID: 32635722
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Lability landscape and protease resistance of human insulin amyloid: a new insight into its molecular properties.
    Malisauskas M; Weise C; Yanamandra K; Wolf-Watz M; Morozova-Roche L
    J Mol Biol; 2010 Feb; 396(1):60-74. PubMed ID: 19913026
    [TBL] [Abstract][Full Text] [Related]  

  • 46. An Aggregate Weight-Normalized Thioflavin-T Measurement Scale for Characterizing Polymorphic Amyloids and Assembly Intermediates.
    Wetzel R; Chemuru S; Misra P; Kodali R; Mukherjee S; Kar K
    Methods Mol Biol; 2018; 1777():121-144. PubMed ID: 29744831
    [TBL] [Abstract][Full Text] [Related]  

  • 47. On the Molecular Form of Amyloid Marker, Auramine O, in Human Insulin Fibrils.
    Mudliar NH; Pettiwala AM; Awasthi AA; Singh PK
    J Phys Chem B; 2016 Dec; 120(49):12474-12485. PubMed ID: 27973839
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Vortex-induced amyloid superstructures of insulin and its component A and B chains.
    Babenko V; Piejko M; Wójcik S; Mak P; Dzwolak W
    Langmuir; 2013 Apr; 29(17):5271-8. PubMed ID: 23590193
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Heterogeneity and Turnover of Intermediates during Amyloid-β (Aβ) Peptide Aggregation Studied by Fluorescence Correlation Spectroscopy.
    Tiiman A; Jarvet J; Gräslund A; Vukojević V
    Biochemistry; 2015 Dec; 54(49):7203-11. PubMed ID: 26574169
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Kinetic studies of protein L aggregation and disaggregation.
    Cellmer T; Douma R; Huebner A; Prausnitz J; Blanch H
    Biophys Chem; 2007 Feb; 125(2-3):350-9. PubMed ID: 17055144
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Role of a novel excipient poly(ethylene glycol)-b-poly(L-histidine) in retention of physical stability of insulin in aqueous solutions.
    Taluja A; Bae YH
    Pharm Res; 2007 Aug; 24(8):1517-26. PubMed ID: 17385016
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Stopped-flow kinetics reveal multiple phases of thioflavin T binding to Alzheimer beta (1-40) amyloid fibrils.
    LeVine H
    Arch Biochem Biophys; 1997 Jun; 342(2):306-16. PubMed ID: 9186492
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Beta-lactoglobulin assembles into amyloid through sequential aggregated intermediates.
    Giurleo JT; He X; Talaga DS
    J Mol Biol; 2008 Sep; 381(5):1332-48. PubMed ID: 18590743
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Amyloid nucleation triggered by agitation of beta2-microglobulin under acidic and neutral pH conditions.
    Sasahara K; Yagi H; Sakai M; Naiki H; Goto Y
    Biochemistry; 2008 Feb; 47(8):2650-60. PubMed ID: 18211100
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The effect of exposing a critical hydrophobic patch on amyloidogenicity and fibril structure of insulin.
    Li Y; Huang L; Yang X; Wang C; Sun Y; Gong H; Liu Y; Zheng L; Huang K
    Biochem Biophys Res Commun; 2013 Oct; 440(1):56-61. PubMed ID: 24041697
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Kinetic mechanism of p53 oncogenic mutant aggregation and its inhibition.
    Wilcken R; Wang G; Boeckler FM; Fersht AR
    Proc Natl Acad Sci U S A; 2012 Aug; 109(34):13584-9. PubMed ID: 22869713
    [TBL] [Abstract][Full Text] [Related]  

  • 57. PicoGreen: a better amyloid probe than Thioflavin-T.
    Mora AK; Singh PK; Patro BS; Nath S
    Chem Commun (Camb); 2016 Oct; 52(82):12163-12166. PubMed ID: 27709200
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Promotion of insulin aggregation by protein disulfide isomerase.
    Maeda R; Ado K; Takeda N; Taniguchi Y
    Biochim Biophys Acta; 2007 Dec; 1774(12):1619-27. PubMed ID: 17920002
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Near-field scanning optical microscopy measurements of fluorescent molecular probes binding to insulin amyloid fibrils.
    Kitts CC; Vanden Bout DA
    J Phys Chem B; 2009 Sep; 113(35):12090-5. PubMed ID: 19663402
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Oligomers, protofibrils and amyloid fibrils from recombinant human lysozyme (rHL): fibrillation process and cytotoxicity evaluation for ARPE-19 cell line.
    Ruiz ED; Almada M; Burboa MG; Taboada P; Mosquera V; Valdez MA; Juárez J
    Colloids Surf B Biointerfaces; 2015 Feb; 126():335-43. PubMed ID: 25618793
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.